IL17A and multiple sclerosis: NOD2 variants are associated with a high level of IL-17 in PBMC from patients with multiple sclerosis or with ocular toxoplasmosis stimulated with myelin-basic protein and soluble Toxoplasma antigen, respectively [37, 38].